US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Sionna Therapeutics

4.87

-0.0350-0.71%

Volume:284.75K

Turnover:1.40M

Market Cap:218.92M

PE:-2.24

High:5.12

Open:4.93

Low:4.83

Close:4.90

52wk High:54.97

52wk Low:4.01

Shares:45.00M

Float Shares:16.73M

Volume Ratio:0.36

T/O Rate:1.70%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1683

EPS(LYR):-1.8835

ROE:-32.34%

ROA:-21.54%

PB:0.82

PE(LYR):-2.58

Loading ...

Overview Company News Filings

Sionna Therapeutics Inc Q2 Operating Expenses USD 32.47 Million

THOMSON REUTERS

Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says

MT Newswires Live

Guggenheim Keeps Their Buy Rating on Sionna Therapeutics, Inc. (SION)

Sionna Therapeutics, Inc. (SION) Receives a Rating Update from a Top Analyst

Sionna Therapeutics (SION) Stock Looks Pricey On Assets But Strong On Returns

Simply Wall St.

Sionna Therapeutics rises 9.2%

Orbimed Advisors Disposes of 85,918 Sionna Therapeutics Shares Worth $3.85 Million

Sionna Therapeutics Chief Legal Officer Jennifer Fitzpatrick Disposes of 10,250 Common Shares Worth $446,862.08

Orbimed Advisors Disposes of 115,844 Sionna Therapeutics Shares Worth $5.27 Million

Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Janux Therapeutics Inc (JANX)

Sionna Therapeutics: Buy Rating Reiterated on NBD1-Focused CF Strategy; $60 Price Target Maintained

Sionna Therapeutics shareholders elect Class II directors at annual meeting

Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Hinge Health, Inc. Class A (HNGE)

OrbiMed Advisors reports Sionna Therapeutics common stock sale valued at $4,493.49

Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences

Sionna Therapeutics Price Target Maintained With a $63.00/Share by Citizens

Stifel Nicolaus Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)

Sionna Therapeutics Cut to Hold From Buy by Freedom Broker

Sionna Therapeutics downgraded at Freedom Broker with unchanged target

Wedbush Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/SION/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SION","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SION\",,,,,undefined,":{"symbol":"SION","market":"US","secType":"STK","nameCN":"Sionna Therapeutics","latestPrice":4.865,"timestamp":1791570061579,"preClose":4.9,"halted":0,"volume":284752,"delay":0,"changeRate":-0.007142857142857171,"floatShares":16725500,"shares":44998073,"eps":-2.16827,"marketStatus":"Trading","change":-0.035,"latestTime":"10-09 14:21:25 EDT","open":4.93,"high":5.12,"low":4.83,"amount":1404609.9439216,"amplitude":0.059184,"askPrice":4.87,"askSize":293,"bidPrice":4.86,"bidSize":662,"shortable":3,"etf":0,"ttmEps":-2.16827,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"listingDate":1738904400000,"exchange":"NASDAQ","adjPreClose":4.9,"preHourTrading":{"tag":"盘前","latestPrice":4.9136,"preClose":4.9,"latestTime":"09:20 EDT","volume":143,"amount":693.513535,"timestamp":1791552008369,"change":0.0136,"changeRate":0.002776,"amplitude":0.016327},"postHourTrading":{"tag":"盘后","latestPrice":4.905,"preClose":4.9,"latestTime":"19:38 EDT","volume":2611,"amount":12795.875,"timestamp":1791502724189,"change":0.005,"changeRate":0.00102,"amplitude":0.00102},"volumeRatio":0.35781,"impliedVol":3.3631,"impliedVolPercentile":0.9931},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SION\",,,,,undefined,":{"symbol":"SION","floatShares":16725500,"roa":"-21.54%","roe":"-32.34%","lyrEps":-1.883481,"volumeRatio":0.35781,"shares":44998073,"dividePrice":0,"high":5.12,"amplitude":0.059184,"preClose":4.9,"low":4.83,"week52Low":4.01,"pbRate":"0.82","week52High":54.97,"institutionHeld":0,"latestPrice":4.865,"committee":0.386387,"eps":-2.16827,"divideRate":0,"volume":284752,"delay":0,"ttmEps":-2.16827,"open":4.93,"prevYearClose":41.14,"prevWeekClose":4.91,"prevMonthClose":5.26,"prevQuarterClose":5.26,"fiveDayClose":4.91,"twentyDayClose":7.85,"sixtyDayClose":45.29},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SION\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"SION","fiscalQuarterEnding":"2026/06","expectedEps":-0.64,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.66},{"market":"US","date":"2026-05-12","symbol":"SION","fiscalQuarterEnding":"2026/03","expectedEps":-0.52,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"pre","actualEps":-0.6},{"market":"US","date":"2026-03-02","symbol":"SION","fiscalQuarterEnding":"2025/12","expectedEps":-0.61,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772427600000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2025-11-05","symbol":"SION","fiscalQuarterEnding":"2025/09","expectedEps":-0.52,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2025-08-11","symbol":"SION","fiscalQuarterEnding":"2025/06","expectedEps":-0.68,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.41}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SION\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SION\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.0909,"hold":0.9091,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.9091,"analysts":11,"updateTime":1786420800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SION\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SION","date":"2026-10-08","current":-2.243724,"percent":0.995215,"low":-28.087165,"twenty":-23.854224,"median":-17.059009,"eighty":-9.221432,"high":-2.089233,"avg":-16.56528,"sd":7.63933,"marketCap":217923763},"quantilePoints":[{"date":"2025-02-07","current":-13.261013,"twenty":-12.252025,"median":-10.738543,"eighty":-9.22506,"marketCap":765372600},{"date":"2025-02-14","current":-14.940741,"twenty":-16.115077,"median":-14.940741,"eighty":-13.535074,"marketCap":862319796},{"date":"2025-02-21","current":-15.365065,"twenty":-15.365065,"median":-14.763927,"eighty":-14.631317,"marketCap":886810118},{"date":"2025-02-28","current":-11.280197,"twenty":-15.101402,"median":-14.760244,"eighty":-13.045594,"marketCap":651047865},{"date":"2025-03-07","current":-11.960372,"twenty":-15.059369,"median":-14.631317,"eighty":-11.310767,"marketCap":690304817},{"date":"2025-03-14","current":-13.068521,"twenty":-15.036515,"median":-13.072343,"eighty":-11.387191,"marketCap":754262771},{"date":"2025-03-21","current":-10.607665,"twenty":-14.940741,"median":-12.594692,"eighty":-11.280197,"marketCap":612232003},{"date":"2025-03-28","current":-8.569094,"twenty":-14.763927,"median":-12.189644,"eighty":-10.607665,"marketCap":528610240},{"date":"2025-04-04","current":-8.304439,"twenty":-14.75656,"median":-11.44833,"eighty":-8.654927,"marketCap":512284214},{"date":"2025-04-11","current":-5.47907,"twenty":-14.719724,"median":-11.345158,"eighty":-8.304439,"marketCap":337992858},{"date":"2025-04-17","current":-7.152833,"twenty":-14.648998,"median":-11.146455,"eighty":-7.438946,"marketCap":441243940},{"date":"2025-04-25","current":-9.012569,"twenty":-13.535074,"median":-10.607665,"eighty":-7.830921,"marketCap":555967364},{"date":"2025-05-02","current":-9.227154,"twenty":-13.113134,"median":-10.157913,"eighty":-8.049798,"marketCap":569204682},{"date":"2025-05-09","current":-8.991111,"twenty":-13.07005,"median":-9.363058,"eighty":-8.189398,"marketCap":554643632},{"date":"2025-05-16","current":-8.935031,"twenty":-13.050179,"median":-9.227154,"eighty":-8.189398,"marketCap":592598052},{"date":"2025-05-23","current":-8.649163,"twenty":-12.684872,"median":-9.227154,"eighty":-8.258154,"marketCap":573638442},{"date":"2025-05-30","current":-9.380453,"twenty":-12.498397,"median":-9.212848,"eighty":-8.290133,"marketCap":622139770},{"date":"2025-06-06","current":-10.656886,"twenty":-12.42503,"median":-9.227154,"eighty":-8.395596,"marketCap":706796635},{"date":"2025-06-13","current":-11.295102,"twenty":-12.251212,"median":-9.28738,"eighty":-8.459628,"marketCap":749125067},{"date":"2025-06-20","current":-9.792634,"twenty":-12.067794,"median":-9.313972,"eighty":-8.462287,"marketCap":649476883},{"date":"2025-06-27","current":-9.859115,"twenty":-11.920631,"median":-9.377129,"eighty":-8.491142,"marketCap":653886095},{"date":"2025-07-03","current":-14.087299,"twenty":-12.050418,"median":-9.569923,"eighty":-8.540482,"marketCap":934311959},{"date":"2025-07-11","current":-13.921097,"twenty":-12.562594,"median":-9.646376,"eighty":-8.576247,"marketCap":923288929},{"date":"2025-07-18","current":-12.185946,"twenty":-12.955414,"median":-9.792431,"eighty":-8.606288,"marketCap":808208504},{"date":"2025-07-25","current":-12.724441,"twenty":-12.981363,"median":-9.952188,"eighty":-8.61201,"marketCap":843923119},{"date":"2025-08-01","current":-11.142196,"twenty":-12.981363,"median":-10.527086,"eighty":-8.61201,"marketCap":738983880},{"date":"2025-08-08","current":-11.487897,"twenty":-12.719123,"median":-10.607665,"eighty":-8.619441,"marketCap":761911781},{"date":"2025-08-15","current":-12.17004,"twenty":-12.719123,"median":-10.776552,"eighty":-8.650316,"marketCap":922963698},{"date":"2025-08-22","current":-13.817157,"twenty":-12.981363,"median":-10.951574,"eighty":-8.660649,"marketCap":1047879398},{"date":"2025-08-29","current":-14.969557,"twenty":-13.185819,"median":-11.135548,"eighty":-8.685971,"marketCap":1135276247},{"date":"2025-09-05","current":-13.421384,"twenty":-13.261013,"median":-11.264381,"eighty":-8.6957,"marketCap":1017864318},{"date":"2025-09-12","current":-13.849168,"twenty":-13.582045,"median":-11.295102,"eighty":-8.81229,"marketCap":1050307088},{"date":"2025-09-19","current":-13.520327,"twenty":-13.543608,"median":-11.380538,"eighty":-8.928383,"marketCap":1025368088},{"date":"2025-09-26","current":-16.005553,"twenty":-13.817157,"median":-11.448008,"eighty":-8.935031,"marketCap":1213845132},{"date":"2025-10-03","current":-17.053189,"twenty":-13.934393,"median":-11.481249,"eighty":-8.974919,"marketCap":1293296813},{"date":"2025-10-10","current":-16.50027,"twenty":-14.087299,"median":-11.594266,"eighty":-8.991111,"marketCap":1251363982},{"date":"2025-10-17","current":-19.043698,"twenty":-14.329335,"median":-11.773765,"eighty":-9.012569,"marketCap":1444255008},{"date":"2025-10-24","current":-23.047996,"twenty":-14.678547,"median":-11.960372,"eighty":-9.101233,"marketCap":1747936990},{"date":"2025-10-31","current":-22.122584,"twenty":-14.777491,"median":-12.128534,"eighty":-9.127014,"marketCap":1677754672},{"date":"2025-11-07","current":-21.722088,"twenty":-15.059369,"median":-12.17004,"eighty":-9.148473,"marketCap":1535230307},{"date":"2025-11-14","current":-22.656643,"twenty":-15.557397,"median":-12.201274,"eighty":-9.173508,"marketCap":1601280913},{"date":"2025-11-21","current":-24.588899,"twenty":-16.50027,"median":-12.318908,"eighty":-9.207602,"marketCap":1737845004},{"date":"2025-11-28","current":-27.51254,"twenty":-16.690008,"median":-12.434201,"eighty":-9.211799,"marketCap":1944476293},{"date":"2025-12-05","current":-25.813923,"twenty":-17.070649,"median":-12.542534,"eighty":-9.224293,"marketCap":1824424853},{"date":"2025-12-12","current":-26.344347,"twenty":-17.43383,"median":-12.644664,"eighty":-9.227154,"marketCap":1861913035},{"date":"2025-12-19","current":-27.916672,"twenty":-18.615331,"median":-12.828464,"eighty":-9.244321,"marketCap":1973038717},{"date":"2025-12-26","current":-27.799853,"twenty":-20.840976,"median":-13.015231,"eighty":-9.271873,"marketCap":1964782391},{"date":"2026-01-02","current":-25.978102,"twenty":-21.880226,"median":-13.072343,"eighty":-9.298017,"marketCap":1836028338},{"date":"2026-01-09","current":-23.111292,"twenty":-22.280894,"median":-13.196456,"eighty":-9.333606,"marketCap":1633413640},{"date":"2026-01-16","current":-24.532068,"twenty":-22.755262,"median":-13.25865,"eighty":-9.367357,"marketCap":1733828413},{"date":"2026-01-23","current":-26.375919,"twenty":-23.010449,"median":-13.309024,"eighty":-9.375135,"marketCap":1864144474},{"date":"2026-01-30","current":-26.798995,"twenty":-23.217376,"median":-13.467945,"eighty":-9.407045,"marketCap":1894045762},{"date":"2026-02-06","current":-22.258826,"twenty":-24.10394,"median":-13.562826,"eighty":-9.536018,"marketCap":1573164777},{"date":"2026-02-13","current":-23.768006,"twenty":-23.957443,"median":-13.817157,"eighty":-9.627762,"marketCap":1679827580},{"date":"2026-02-20","current":-23.578569,"twenty":-24.004802,"median":-13.914449,"eighty":-9.63308,"marketCap":1666438943},{"date":"2026-02-27","current":-23.99533,"twenty":-24.004802,"median":-13.951438,"eighty":-9.646376,"marketCap":1695893944},{"date":"2026-03-06","current":-20.661282,"twenty":-23.99533,"median":-14.087299,"eighty":-9.713547,"marketCap":1555133402},{"date":"2026-03-13","current":-21.928699,"twenty":-23.824837,"median":-14.227481,"eighty":-9.792228,"marketCap":1650529317},{"date":"2026-03-20","current":-21.217272,"twenty":-23.768006,"median":-14.329335,"eighty":-9.792634,"marketCap":1596981610},{"date":"2026-03-27","current":-22.693932,"twenty":-23.692231,"median":-14.628741,"eighty":-9.859115,"marketCap":1708126851},{"date":"2026-04-02","current":-24.690711,"twenty":-23.779372,"median":-14.699136,"eighty":-9.933573,"marketCap":1858420414},{"date":"2026-04-10","current":-23.249921,"twenty":-23.779372,"median":-14.763927,"eighty":-10.393622,"marketCap":1749975058},{"date":"2026-04-17","current":-27.046193,"twenty":-23.997224,"median":-14.955149,"eighty":-10.519675,"marketCap":2035712822},{"date":"2026-04-24","current":-22.927089,"twenty":-24.052712,"median":-15.059369,"eighty":-10.529177,"marketCap":1725676099},{"date":"2026-05-01","current":-23.210503,"twenty":-24.014274,"median":-15.233234,"eighty":-10.592246,"marketCap":1747008171},{"date":"2026-05-08","current":-25.975372,"twenty":-24.255396,"median":-15.761105,"eighty":-10.607665,"marketCap":1955114312},{"date":"2026-05-15","current":-22.568569,"twenty":-24.314473,"median":-16.442494,"eighty":-10.647042,"marketCap":1931079614},{"date":"2026-05-22","current":-22.030343,"twenty":-24.255396,"median":-16.587573,"eighty":-10.662204,"marketCap":1885026277},{"date":"2026-05-29","current":-22.584399,"twenty":-24.225568,"median":-16.843662,"eighty":-10.799155,"marketCap":1932434124},{"date":"2026-06-05","current":-19.935481,"twenty":-24.091149,"median":-17.056099,"eighty":-10.92148,"marketCap":1705779467},{"date":"2026-06-12","current":-19.022607,"twenty":-24.014274,"median":-17.123032,"eighty":-10.948046,"marketCap":1627669396},{"date":"2026-06-18","current":-19.381425,"twenty":-24.010485,"median":-17.425682,"eighty":-10.97603,"marketCap":1658371620},{"date":"2026-06-26","current":-22.568569,"twenty":-24.001013,"median":-17.729808,"eighty":-11.059188,"marketCap":1931079614},{"date":"2026-07-02","current":-21.972299,"twenty":-23.989729,"median":-17.973475,"eighty":-11.131559,"marketCap":1880059741},{"date":"2026-07-10","current":-23.713619,"twenty":-23.938829,"median":-18.418073,"eighty":-11.16347,"marketCap":2029055830},{"date":"2026-07-17","current":-23.898305,"twenty":-23.898305,"median":-18.702419,"eighty":-11.254892,"marketCap":2044858445},{"date":"2026-07-24","current":-23.249267,"twenty":-23.989729,"median":-18.996224,"eighty":-11.281848,"marketCap":1989323539},{"date":"2026-07-31","current":-24.684537,"twenty":-24.004802,"median":-19.043698,"eighty":-11.288454,"marketCap":2112132437},{"date":"2026-08-07","current":-23.001015,"twenty":-24.109374,"median":-19.37351,"eighty":-11.295102,"marketCap":2239907871},{"date":"2026-08-14","current":-3.036352,"twenty":-24.014274,"median":-19.249507,"eighty":-11.248566,"marketCap":295689089},{"date":"2026-08-21","current":-2.562793,"twenty":-24.014274,"median":-19.009416,"eighty":-10.951574,"marketCap":249572442},{"date":"2026-08-28","current":-2.813501,"twenty":-24.004802,"median":-18.741047,"eighty":-10.656886,"marketCap":273987137},{"date":"2026-09-04","current":-3.13385,"twenty":-23.99533,"median":-18.500988,"eighty":-10.523599,"marketCap":305183693},{"date":"2026-09-11","current":-3.537768,"twenty":-23.972928,"median":-18.163438,"eighty":-9.845819,"marketCap":344518480},{"date":"2026-09-18","current":-3.333488,"twenty":-23.950101,"median":-17.777299,"eighty":-9.643717,"marketCap":324625024},{"date":"2026-09-25","current":-2.428153,"twenty":-23.907803,"median":-17.446053,"eighty":-9.379123,"marketCap":236460846},{"date":"2026-10-02","current":-2.367798,"twenty":-23.898305,"median":-17.123032,"eighty":-9.279627,"marketCap":230583234},{"date":"2026-10-08","current":-2.237801,"twenty":-23.854224,"median":-17.059009,"eighty":-9.221432,"marketCap":217923763}],"updateTime":1791570085723},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SION\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657680210","title":"Sionna Therapeutics Inc Q2 Operating Expenses USD 32.47 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657680210","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657680210?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:00","pubTimestamp":1786014005,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXQHVW7V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657255048","title":"Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2657255048","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657255048?lang=en_us&edition=fundamental","pubTime":"2026-08-05 00:02","pubTimestamp":1785859337,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals  reported a solid Q2 and raised its outlook, highlighting the strength of its core business and pipeline, RBC Capital Markets said in a note emailed Tuesday.The analysts said the stock could benefit once the Sionna Therapeutics  data overhang clears, with upcoming catalysts including the launch of new products, the expected closing of the Crinetics Pharmaceuticals  deal, and additional pipeline readouts.The stock does not fully reflect the potential upside from pipeline opportunities, including kidney programs, expansion of povetacicept into autoimmune diseases such as IgA nephropathy and generalized myasthenia gravis, and the longer-term potential of suzetrigine in chronic pain, the analysts added.\"We believe that given Vertex's strong core revenue, a pipeline that is increasingly becoming more mature, and with optionality to further diversify pipeline with external [business development,] shares should command a higher valuation,\" the analysts said.RBC lowered ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2362540622.SGD","IBB","BK4533","PBE","LU1674673691.USD","LU0234570918.USD","LU0823416689.USD","LU0566484027.USD","LU1585245621.USD","LU2237438978.USD","VRTX","LU2468319806.SGD","BK4532","BK4567","LU1674673428.USD","LU2362541513.USD","GNMX","LU0432979614.USD","CRNX","LU1035775433.USD","IE0002270589.USD","LU2456880835.USD","LU1815336091.USD","LU1778281490.HKD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU2236285917.USD","LU0256863811.USD","BK4585","BK4139","IE0009355771.USD","LU0320765992.SGD","LU2324357040.USD","IDNA","VERX","LU0417517546.SGD","SGXZ57979304.SGD","LU0889565916.HKD","BIB","LU1430594728.SGD","BBH","BK4588","IE00B19Z3B42.SGD","LU0061475181.USD","SION","TBXU","LU1093756325.SGD","IBBQ","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654012448","title":"Guggenheim Keeps Their Buy Rating on Sionna Therapeutics, Inc. (SION)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654012448","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654012448?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:37","pubTimestamp":1785152258,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Yatin Suneja reiterated a Buy rating on Sionna Therapeutics, Inc. on July 24 and set a price target of $50.00. The company’s sha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-keeps-their-buy-rating-on-sionna-therapeutics-inc-sion-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-keeps-their-buy-rating-on-sionna-therapeutics-inc-sion-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652216154","title":"Sionna Therapeutics, Inc. (SION) Receives a Rating Update from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2652216154","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652216154?lang=en_us&edition=fundamental","pubTime":"2026-07-20 21:15","pubTimestamp":1784553345,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Ritu Baral maintained a Buy rating on Sionna Therapeutics, Inc. on July 17 and set a price target of $49.41. The company’s shares ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/sionna-therapeutics-inc-sion-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/sionna-therapeutics-inc-sion-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652255498","title":"Sionna Therapeutics (SION) Stock Looks Pricey On Assets But Strong On Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2652255498","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652255498?lang=en_us&edition=fundamental","pubTime":"2026-07-19 11:27","pubTimestamp":1784431621,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics stock has delivered a sharp 195.2% return over the past year, yet its low value score and overvalued reading on the market multiples raise questions about how much upside is already reflected in the price.\n\nOver the past 1 year, Sionna Therapeutics has returned 195.2%, which puts the recent share price strength firmly in focus for anyone thinking about valuation.\nExpectations for the company’s drug pipeline can support a premium, but uncertainty around execution,...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sion/sionna-therapeutics/news/sionna-therapeutics-sion-stock-looks-pricey-on-assets-but-st","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sion/sionna-therapeutics/news/sionna-therapeutics-sion-stock-looks-pricey-on-assets-but-st","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","SION","TSPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652428428","title":"Sionna Therapeutics rises 9.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652428428","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652428428?lang=en_us&edition=fundamental","pubTime":"2026-07-18 00:06","pubTimestamp":1784304406,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics (SION) is up 9.2%, or $4.15 to $49.44. Published first on TheFly – the ultimate source for real-time, market-moving breaking fi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-rises-9-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-rises-9-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650897282","title":"Orbimed Advisors Disposes of 85,918 Sionna Therapeutics Shares Worth $3.85 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2650897282","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650897282?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:44","pubTimestamp":1783629894,"startTime":"0","endTime":"0","summary":"OrbiMed Advisors disposes of 85,918 Sionna Therapeutics shares worth $3.85 millionOrbiMed Advisors reported selling 85,918 Sionna Therapeutics common shares on July 7, 2026 at USD 44.86.Indirect stake","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nNDL6SVrls:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Orbimed Advisors Disposes of 85,918 Sionna Therapeutics Shares Worth $3.85 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649930156","title":"Sionna Therapeutics Chief Legal Officer Jennifer Fitzpatrick Disposes of 10,250 Common Shares Worth $446,862.08","url":"https://stock-news.laohu8.com/highlight/detail?id=2649930156","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649930156?lang=en_us&edition=fundamental","pubTime":"2026-07-08 04:38","pubTimestamp":1783456739,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics Chief Legal Officer Jennifer Fitzpatrick disposes of 10,250 common shares worth $446,862.08Sionna Therapeutics Chief Legal Officer Jennifer Fitzpatrick exercised stock options for ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDLb6bh8k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Sionna Therapeutics Chief Legal Officer Jennifer Fitzpatrick Disposes of 10,250 Common Shares Worth $446,862.08","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648633178","title":"Orbimed Advisors Disposes of 115,844 Sionna Therapeutics Shares Worth $5.27 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2648633178","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648633178?lang=en_us&edition=fundamental","pubTime":"2026-07-03 04:43","pubTimestamp":1783025023,"startTime":"0","endTime":"0","summary":"OrbiMed Advisors disposes of 115,844 Sionna Therapeutics shares worth $5.27 millionOrbiMed Advisors reported selling 115,844 Sionna Therapeutics common shares on June 30, 2026 at USD 45.5.Stake fell t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDL9Kcf53:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Orbimed Advisors Disposes of 115,844 Sionna Therapeutics Shares Worth $5.27 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646066338","title":"Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Janux Therapeutics Inc (JANX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2646066338","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646066338?lang=en_us&edition=fundamental","pubTime":"2026-06-25 21:50","pubTimestamp":1782395411,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sionna Therapeutics, Inc. (SION) and Janux Therapeut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sionna-therapeutics-inc-sion-and-janux-therapeutics-inc-janx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sionna-therapeutics-inc-sion-and-janux-therapeutics-inc-janx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","JANX","LU0029874061.USD","BK4588","LABU","BK4139","XLV","SION","BK4539","BK4585","BK4581","HCSG","BK4137","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029180","title":"Sionna Therapeutics: Buy Rating Reiterated on NBD1-Focused CF Strategy; $60 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029180?lang=en_us&edition=fundamental","pubTime":"2026-06-22 18:46","pubTimestamp":1782125197,"startTime":"0","endTime":"0","summary":"Analyst Gaurav Maini from LifeSci Capital maintained a Buy rating on Sionna Therapeutics, Inc. and keeping the price target at $60.00. Gaurav Maini...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sionna-therapeutics-buy-rating-reiterated-on-nbd1-focused-cf-strategy-60-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sionna-therapeutics-buy-rating-reiterated-on-nbd1-focused-cf-strategy-60-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION","CF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644608036","title":"Sionna Therapeutics shareholders elect Class II directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2644608036","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644608036?lang=en_us&edition=fundamental","pubTime":"2026-06-19 04:06","pubTimestamp":1781813188,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics held its annual shareholder meeting on June 17, 2026.Shareholders backed the selection of four Class II directors, with each nominee approved to serve until the 2029 annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDLY2swc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642285703","title":"Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Hinge Health, Inc. Class A (HNGE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642285703","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642285703?lang=en_us&edition=fundamental","pubTime":"2026-06-11 18:30","pubTimestamp":1781173823,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sionna Therapeutics, Inc. (SION) and Hinge Health, I...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sionna-therapeutics-inc-sion-and-hinge-health-inc-class-a-hnge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sionna-therapeutics-inc-sion-and-hinge-health-inc-class-a-hnge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4585","BK4588","BK4139","XBI","XLV","BK4196","LU0029874061.USD","BK4581","LU0128526141.USD","LABU","HNGE","BK4137","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639036696","title":"OrbiMed Advisors reports Sionna Therapeutics common stock sale valued at $4,493.49","url":"https://stock-news.laohu8.com/highlight/detail?id=2639036696","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639036696?lang=en_us&edition=fundamental","pubTime":"2026-05-30 08:58","pubTimestamp":1780102681,"startTime":"0","endTime":"0","summary":"OrbiMed Advisors LLC reported selling 101 shares of Sionna Therapeutics common stock on May 27, 2026.Shares sold at USD 44.49; indirect beneficial ownership fell to 2,671,721 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nNDL1zPSmG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"OrbiMed Advisors reports Sionna Therapeutics common stock sale valued at $4,493.49","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638507006","title":"Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2638507006","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638507006?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:00","pubTimestamp":1779883200,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., May  27, 2026  (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/27/3301841/0/en/Sionna-Therapeutics-to-Participate-in-Upcoming-June-2026-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CF","BK4139","SION","BK4093","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638105565","title":"Sionna Therapeutics Price Target Maintained With a $63.00/Share by Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2638105565","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638105565?lang=en_us&edition=fundamental","pubTime":"2026-05-26 21:31","pubTimestamp":1779802260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SION/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 26, 2026 09:31 ET (13:31 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638553071","title":"Stifel Nicolaus Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638553071","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638553071?lang=en_us&edition=fundamental","pubTime":"2026-05-25 21:56","pubTimestamp":1779717394,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Sionna Therapeutics, Inc. today and set a price target of $55.00. According to TipR...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-sticks-to-their-buy-rating-for-sionna-therapeutics-inc-sion-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-sticks-to-their-buy-rating-for-sionna-therapeutics-inc-sion-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637821956","title":"Sionna Therapeutics Cut to Hold From Buy by Freedom Broker","url":"https://stock-news.laohu8.com/highlight/detail?id=2637821956","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637821956?lang=en_us&edition=fundamental","pubTime":"2026-05-21 00:39","pubTimestamp":1779295140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SION/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 20, 2026 12:39 ET (16:39 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636819826","title":"Sionna Therapeutics downgraded at Freedom Broker with unchanged target","url":"https://stock-news.laohu8.com/highlight/detail?id=2636819826","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636819826?lang=en_us&edition=fundamental","pubTime":"2026-05-20 22:50","pubTimestamp":1779288610,"startTime":"0","endTime":"0","summary":"As previously reported, Freedom Broker analyst Ilya Zubkov downgraded Sionna Therapeutics (SION) to Hold from Buy with an unchanged price target of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-downgraded-at-freedom-broker-with-unchanged-target-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-downgraded-at-freedom-broker-with-unchanged-target-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636076531","title":"Wedbush Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636076531","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636076531?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:59","pubTimestamp":1779109150,"startTime":"0","endTime":"0","summary":"Wedbush analyst Laura Chico maintained a Buy rating on Sionna Therapeutics, Inc. today and set a price target of $53.00. According to TipRanks, Chi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wedbush-sticks-to-their-buy-rating-for-sionna-therapeutics-inc-sion-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wedbush-sticks-to-their-buy-rating-for-sionna-therapeutics-inc-sion-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":116,"code":"91000000","status":"200"}]}}